Skip to content

Comparison of acupuncture and botox in prevention of chronic migraine

The comparison of treatment effect between acupuncture and botox injection effects on prevention of chronic migraine among patients referred to pain clinic of Poursina hospital in 2014

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201404146186N3
Enrollment
100
Registered
2014-04-30
Start date
2014-05-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine. Migraine

Interventions

Intervention 1: Intervention1: Botox, 155 unit Botulinum toxin XEOMIN, GERMANY, Merz Group Services GmbH, in one time injection. Intervention 2: Intervention 2: Acupuncture, every other day up to 15 t
Treatment - Drugs
Treatment - Other
Intervention1: Botox, 155 unit Botulinum toxin XEOMIN, GERMANY, Merz Group Services GmbH, in one time injection
Intervention 2: Acupuncture, every other day up to 15 times in two period , one week interval, along 70 days from initial of treatment

Sponsors

Vice chancellor of Guilan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:the patient aged 20 to 60 years old that have chronic migraine (with HIS criteria) that come to Rasht poursina hospital pain clinic in 2014. Exclusion criteria: other reasons of headache such as brain tumor; the people that have other headache addition to migraine; pregnant women; psychotic disorder or mental retardation, epilepsy; history of neurological disorder, heart disease and trauma, arterial hypertension; patient dissatisfaction to enter in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: Referral time, the end of first month, end of second month and the end of third month. Method of measurement: VAS score.

Secondary

MeasureTime frame
Frecuancy of headache in month. Timepoint: Referral time,the end of first month, end of second month and the end of third month. Method of measurement: Incidence number of migraine headache with IHS.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Bahram Naderi Nabi

Guilan University of Medical Sciences

naderi_bahram@yahoo.com;arcguilan1392@gmail.com+98 13 1321 0434

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026